ZC3H7A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.147650E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.023800E-02
Normal-vs-Stage2
6.192400E-04
Normal-vs-Stage3
9.362400E-02
Normal-vs-Stage4
1.576640E-01
Stage1-vs-Stage2
6.620800E-01
Stage1-vs-Stage3
3.836000E-02
Stage1-vs-Stage4
6.864400E-01
Stage2-vs-Stage3
3.149600E-02
Stage2-vs-Stage4
3.962200E-01
Stage3-vs-Stage4
1.554180E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.532170E-02
Normal-vs-AfricanAmerican
3.273600E-02
Normal-vs-Asian
2.022300E-02
Caucasian-vs-AfricanAmerican
8.670000E-01
Caucasian-vs-Asian
2.486800E-01
AfricanAmerican-vs-Asian
5.034600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.157400E-03
Normal-vs-Female
4.537900E-02
Male-vs-Female
3.976600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.203760E-01
Normal-vs-Age(41-60Yrs)
1.242430E-01
Normal-vs-Age(61-80Yrs)
1.097790E-03
Normal-vs-Age(81-100Yrs)
9.015000E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.486000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.726800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.902200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.673500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.830450E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.716400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.864980E-03
Normal-vs-Daily Drinker
1.584250E-03
Normal-vs-Weekly Drinker
1.852360E-02
Normal-vs-Occasional Drinker
2.544000E-02
Normal-vs-Social Drinker
5.480800E-01
Non Drinker-vs-Daily Drinker
5.845800E-01
Non Drinker-vs-Weekly Drinker
6.910400E-01
Non Drinker-vs-Occasional Drinker
3.144400E-01
Non Drinker-vs-Social Drinker
2.241200E-01
Daily Drinker-vs-Weekly Drinker
9.820400E-01
Daily Drinker-vs-Occasional Drinker
1.659360E-01
Daily Drinker-vs-Social Drinker
1.691850E-01
Weekly Drinker-vs-Occasional Drinker
2.963400E-01
Weekly Drinker-vs-Social Drinker
1.913760E-01
Occasional Drinker-vs-Social Drinker
4.071400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.457990E-01
Normal-vs-Grade 2
3.808900E-04
Normal-vs-Grade 3
5.223500E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.268400E-01
Grade 1-vs-Grade 3
3.561200E-01
Grade 1-vs-Grade 4
1.457990E-01
Grade 2-vs-Grade 3
9.398600E-01
Grade 2-vs-Grade 4
3.808900E-04
Grade 3-vs-Grade 4
5.223500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.143300E-03
Normal-vs-NonDiabetic
2.355900E-02
Diabetic-vs-NonDiabetic
3.526600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.532380E-01
Normal-vs-NoPancreatitis
2.015700E-02
Pancreatitis-vs-NoPancreatitis
1.758980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.327550E-01
Normal-vs-N1
6.038700E-04
N0-vs-N1
3.244000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.368000E-01
Normal-vs-TP53-NonMutant
1.863430E-01
TP53-Mutant-vs-TP53-NonMutant
5.945900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
